Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991008752) METHOD FOR THE TREATMENT OF THROMBOCYTOPENIA AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREFOR
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/008752 International Application No.: PCT/AU1990/000592
Publication Date: 27.06.1991 International Filing Date: 18.12.1990
Chapter 2 Demand Filed: 19.06.1991
IPC:
A61K 38/20 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
20
Interleukins
Applicants:
AMRAD CORPORATION LIMITED [AU/AU]; 17-27 Cotham Road Kew, VIC 3101, AU (AllExceptUS)
METCALF, Donald [AU/AU]; AU (UsOnly)
Inventors:
METCALF, Donald; AU
Agent:
SLATTERY, John, Michael ; Davies & Collison 1 Little Collins Street Melbourne, VIC 3000, AU
Priority Data:
PJ 791218.12.1989AU
PK 350123.11.1990AU
Title (EN) METHOD FOR THE TREATMENT OF THROMBOCYTOPENIA AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREFOR
(FR) PROCEDE DE TRAITEMENT DE LA THROMBOCYTOPENIE ET COMPOSITIONS PHARMACEUTIQUES UTILES
Abstract:
(EN) The present invention relates generally to a method for, and pharmaceutical compositions useful in, the treatment of thrombocytopenia in a mammal by the administration of an effective amount of leukaemia inhibitory factor (LIF) and/or its derivatives and optionally in combination with one or more other cytokines.
(FR) La présente invention a pour objet général un procédé ainsi que des compositions pharmaceutiques utiles relatifs au traitement de la thrombocytopénie chez un mammifère par administration d'une quantité efficace de facteur inhibiteur de la leucémie (LIF) et/ou de ses dérivés et, éventuellement, en combinaison avec une ou plusieurs cytokines.
Designated States: AU, CA, FI, HU, JP, NO, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
FI922839NO19922341EP0506716US5571508CA2071956AU1991069104